DeepWork Capital — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Genascence develops gene therapy treatments for musculoskeletal diseases, with a focus on osteoarthritis.
BiotechHealthtech
Wesley Chapel, US
David Sawyer(Executive Officer, Director)inRalph Stoddard(Director)Stella Parris(Executive Officer)Margaret Sawyer(Director)
BoardKATIE SCHMITZ(Director)JUSTIN KELLY(Director)
Co-investorsBeresford VenturesFlorida FundersJohnson Venture PartnersThird Act Ventures
Urban SDK provides geospatial AI technology for public sector organizations, particularly city governments and transportation agencies, to support data-driven decision-making for urban planning and traffic analytics.
AI & Machine LearningData & InfrastructureGovTechMobility & TransportationAtlantic Beach, US
Justin J. Dennis(Executive Officer, Director)Drew Messer(Founder)inMeredith Pelton(Director)
BoardMitchel Laskey(Director)inJonathan Kilman(Director)
Co-investorsCreativeCoFlorida Opportunity FundGOVO Venture PartnersRiverwood CapitalTechstarsVentureSouth+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.












